-
Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022
-
View Affiliations Hide AffiliationsVincenzo Purovincenzo.puro inmi.it
-
View Citation Hide Citation
Citation style for this article: . Results of an interventional HIV testing programme in the context of a mpox (formerly monkeypox) vaccination campaign in Latium Region, Italy, August to October 2022. Euro Surveill. 2022;27(48):pii=2200890. https://doi.org/10.2807/1560-7917.ES.2022.27.48.2200890 Received: 16 Nov 2022; Accepted: 01 Dec 2022
- Previous Article
- Table of Contents
- Next Article
Abstract
HIV testing was offered to 2,185 people receiving mpox (formerly monkeypox) vaccination, who reported not being HIV positive. Among them 390 were current PrEP users, and 131 had taken PrEP in the past. Of 958 individuals consenting testing, six were newly diagnosed with HIV. Two patients had symptomatic primary HIV infection. None of the six patients had ever taken PrEP. Mpox vaccination represents an important opportunity for HIV testing and counselling about risk reduction and PrEP.
Full text loading...